T1 Protein 9 20 anti-CTLA-4
T2 Condition 22 32 ipilimumab
T3 Organism 317 325 patients
T5 Condition 568 574 tumors
T6 Condition 152 167 prostate cancer
T7 Condition 559 574 prostate tumors
T8 Condition 286 311 ipilimumab-treated tumors
T9 Gene 499 504 VISTA
T10 Condition 286 296 ipilimumab
T11 Condition 469 475 tumors
T12 Organism 37 47 anti-PD-1 
T13 Intervention 446 457 macrophages
T14 Condition 581 591 ipilimumab
T15 Gene 383 388 VISTA
T16 Gene 373 409 PD-L1 and VISTA inhibitory molecules
